News
But when a dividend yield reaches ultrahigh levels, investors can feel a heightened level of uncertainty. Wondering if Pfizer ...
17h
Stocktwits on MSNMerck, Pfizer, Eli Lilly Stocks Rebound As Trump Targets Drug Costs With New Executive OrderPfizer (PFE), and Eli Lilly (LLY) traded in the green Monday morning despite declining in pre-market hours after President ...
3d
24/7 Wall St. on MSNPfizer (NYSE:PFE) Hasn’t Been This Cheap in 13 Years. Time to Buy?Pfizer (NYSE:PFE) is one of the world’s largest pharmaceutical companies, but at $22.59 per share as of this writing, the ...
A combination of the HER2 agent, called disitamab vedotin, and Junshi Biosciences’ PD-1 inhibitor toripalimab outperformed ...
The company disclosed revenue of $13.7 billion and adjusted earnings of $0.92 per share, compared to consensus estimates of ...
Pfizer said on Tuesday it would generate $1.7 billion more in savings from cost cuts to its manufacturing and research ...
Shares of Asian drugmakers are falling after President Trump said he would [sign an executive order]( ...
Pfizer maintained its 2025 guidance but noted it does not include any impact of tariffs or trade policy, “which we are unable ...
Albert Bourla said Pfizer is being "frugal" with investments because of the uncertainty surrounding tariffs.
Pfizer Inc. is cutting at least another $1.2 billion from its spending while the company searches for its next big hit after ...
Big pharmaceutical companies as well as smaller biotechs have been hoping to score a win in one of today's highest-growth ...
Pfizer’s R&D organization has been in flux for almost two years now, since the $43 billion acquisition of ADC specialist ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results